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Abstract
We report the unexpected resolution of longstanding schizophrenic symptoms after starting a low-
carbohydrate, ketogenic diet. After a review of the literature, possible reasons for this include the
metabolic consequences from the elimination of gluten from the diet, and the modulation of the
disease of schizophrenia at the cellular level.
Case report
C.D. is a 70 year-old Caucasian female with a diagnosis of
schizophrenia since the age of seventeen. Her diagnosis
was based on paranoia, disorganized speech, and halluci-
nations. She reported both auditory and visual hallucina-
tions, including seeing skeletons and hearing voices that
told her to hurt herself. According to her history, she has
had these hallucinations on almost a daily basis since the
age of seven. C.D. has also been hospitalized at least five
times over the last six years for suicide attempts and
increased psychotic symptoms. She has attempted to over-
dose on medications, cut herself, and ingest cleaning
agents. Her most recent hospitalization was five months
prior to initiating the low-carbohydrate diet. She has dis-
cussed both her suicidal ideations and her hallucinations
with her psychiatrist who has tried to optimize her medi-
cation regimen in an effort to improve her symptoms, but
this has been largely unsuccessful. Her prior anti-psy-
chotic and mood-stabilizing medication regimen has
included lithium 900 mg qhs, olanzapine (dose
unknown), ziprasidone 40 mg bid, aripiprazole 30 mg
qhs, lamotrigine 100 mg bid, and quetiapine 900 mg qhs.
She is currently managed on risperidone 4 mg qhs.
C.D.'s other medical problems (and approximate year of
diagnosis) included obesity (1950's), hypertension
(1970's), depression (1940's), obstructive sleep apnea
(2002), gastroesophageal reflux disease (2003), urinary
incontinence (2002), glaucoma (1999), trochanteric bur-
sitis (2004), peripheral neuropathy of unknown etiology
(2006), and prior cholecystectomy (1978). Her current
medications included atenolol 100 mg daily, furosemide
20 mg daily, trazodone 100 mg qhs, sertraline 100 mg
daily, timolol eye drops 1 drop each eye bid, brimonidine
eye drops 1 drop each eye bid, and vitamin E 400 IU every
other day.
A typical day's diet consisted of the following: egg and
cheese sandwich, diet soda, water, pimento cheese, barbe-
qued pork, chicken salad, hamburger helper, macaroni
and cheese, and potatoes. She rated her baseline fatigue as
a "3" using a standardized questionnaire (0 = none, 4 =
severe or frequent). Her body weight was 141.4 kilograms
(BMI 52.6 kg/m2), sitting blood pressure (BP) was 130/72
mmHg, and pulse was 68 beats per minute. Physical
examination showed an obese, mildly disheveled female
with poor attention to hygiene, but was otherwise unre-
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markable. She was instructed how to follow a dietary reg-
imen consisting of unlimited meats and eggs, 4 ounces of
hard cheese, 2 cups of salad vegetables, and 1 cup of low-
carbohydrate vegetables per day. This diet restricts carbo-
hydrate intake to fewer than 20 grams per day [1].
She returned for a follow-up appointment 7 days after
starting the low-carbohydrate diet. She was feeling well,
and noted an increase in energy. She was seen again in
clinic 19 days later. When asked how she was doing, she
responded that she was no longer hearing voices or seeing
skeletons. She first noticed this upon awakening about 8
days after starting the program. She had had no change in
medication. The only change had been in her dietary
intake which now consisted of beef, chicken, turkey, ham,
fish, green beans, tomatoes, diet drinks, and water. She
denied hunger. C.D. was very happy that she was no
longer hearing voices, and believed that it made her
calmer. Her body weight was 136.2 kilograms, sitting BP
was 150/84 mmHg, and pulse was 76 beats per minute.
Over the course of 12 months, C.D. has continued the
low-carbohydrate, ketogenic diet and has had no recur-
rence of her auditory or visual hallucinations. She has also
continued to lose weight (body weight 131.4 kilograms)
and experience improvements in her energy level. She
acknowledged having 2–3 isolated episodes of dietary
non-compliance that lasted several days, where she ate
pasta, bread, and cakes around the winter holidays; how-
ever she had no recurrence of her hallucinations.
Discussion
In this case study, the abrupt resolution of longstanding
schizophrenic symptoms was observed after the initiation
of a low-carbohydrate, ketogenic diet used for weight loss.
Previously, Dohan observed a decrease in hospital admis-
sions for schizophrenia in countries that had limited
bread consumption during World War II, which suggested
a possible relationship between bread and schizophrenia
[2]. Dohan and colleagues also observed that overt schiz-
ophrenia was rare in remote tribal areas of several South
Pacific islands where grains were rare, as compared to sim-
ilar populations which had a higher prevalence of overt
schizophrenia and grain consumption [3]. Additionally,
some researchers have previously noted an association
between schizophrenia and celiac disease, an immune-
mediated enteropathy that is triggered by the ingestion of
gluten-containing grains [4].
The treatment of schizophrenia today is largely pharma-
cological, but we found several treatments previously used
or studied related to nutritional factors. There have been
several small controlled studies in which a gluten-free diet
showed promise in ameliorating schizophrenic symp-
toms [4]. In one such study, approximately 10% of schiz-
ophrenic patients had improvement in their symptoms by
elimination of dietary gluten [5]. Another uncontrolled
pilot study using a ketogenic diet (which is typically also
a gluten-free diet because the consumption of gluten-con-
taining bread and starch is eliminated) also suggested
symptomatic improvement among patients with schizo-
phrenia [6]. This study was motivated by the observation
that patients with schizophrenia tended to eat more car-
bohydrates immediately before a psychotic episode. Addi-
tionally, low-carbohydrate, ketogenic diets have a long
history for the treatment of refractory pediatric epilepsy
[7,8] and recently have been studied as a treatment for
obesity and cardiometabolic risk reduction [9,10]. The
mechanism of action for the anti-epileptic effect may be
related to an increase in GABA activity which leads to a
general reduction in excitation [11]. Ketosis was not con-
firmed in C.D. after starting the low-carbohydrate,
ketogenic diet. While checking serum or urinary ketones
may have provided more information to C.D.'s current
metabolic state, ketosis itself may be more effect than
cause if the underlying process is indeed an immune-
mediated reaction to gluten. Still, this is a limitation to
this report.
The diagnosis of celiac disease is often difficult to make,
but serologic tests are available to assist in the diagnosis.
In C.D.'s case, an anti-gliadin IgG assay was performed
and was 13 units (negative < 20 units). While the assay
was negative, it was limited by the fact that it was per-
formed 3 months after the initiation of the low carbohy-
drate diet and thus in the absence of an antigenic
stimulus. Additionally, biopsy-proven celiac disease with-
out serological evidence is a known clinical entity [12].
Dietary conditions other than gluten-sensitivity, such as
vitamin deficiencies, have also been associated with psy-
chosis and schizophrenia. For example, deficiencies in
folate, vitamin C, and niacin have been suggested to
worsen the symptoms of schizophrenia [13]. Further-
more, one study examining the nutritional content of a
low carbohydrate diet found that while there was similar
intake of other vitamins and minerals, the consumption
of fiber and vitamin C was less in the low carbohydrate
diet compared to a low fat diet [14]. In C.D.'s case, she
reported consuming sources of vitamin C (tomatoes) in
her diet history, and her prescribed diet allowed for her to
consume other vitamin C rich foods as well (i.e. squash).
Still, had she consumed less than the recommended
intake of vitamin C, her symptoms should have worsened
instead of improved. It is also unlikely that she would
become overtly deficient in vitamin C after 8 days, which
is when her symptoms changed. The same argument can
be made for folate; because the majority of folic acid is
found in fortified breads and grains, it is logical to assume
then that initiating a gluten-free diet would have wors-Publish with BioMed Central    and   every 
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ened her symptoms, and not improved them. Moreover,
the previously studied doses of niacin (3 g/day) and meth-
ylfolate (15 mg/day) in patients with schizophrenia to
achieve clinical improvement are far greater than what
would be consumed in a typical low carbohydrate diet
[15,16]. Finally, patients with schizophrenia have been
shown to consume less fiber than the general U.S. popu-
lation [17], but there is no data to suggest that altering the
fiber content of a diet will change the symptoms of
patients with schizophrenia.
Conclusion
While more research is needed to confirm the association
between gluten intake and schizophrenia and whether
dietary change can ameliorate schizophrenic symptoms,
health care providers could consider screening patients
with schizophrenia for celiac disease and/or augment the
medical regimen with a gluten-free or low-carbohydrate,
ketogenic diet.
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